New malaria treatment thwarts parasite resistance

Professor Vicky Avery, from the Eskitis Institute for Drug Discovery
Griffith Institute for Drug Discovery (GRIDD)
Scientistsfrom Griffith Universityhave contributed to a breakthrough identifying and characterising a potent agent that thwarts drug resistance in the parasite that causes malaria. In a paper published in the journal Science Translational Medicine, an international research team is reporting the effectiveness of DSM265, a long-acting inhibitor for the treatment and prevention of malaria and which […]